跳至主要内容
临床试验/NCT01708096
NCT01708096已完成不适用

Mechanisms Behind Antidiabetic Effects by Gastric By-pass

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2009年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
2
主要终点
Insulin sensitivity

研究概览

简要总结

The aim of the study is to develop new strategies in treatment of continuous increasing number of patients with type 2 diabetes by understanding how bariatric surgery cures or improves this condition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diabetes typ 2
  • •18-70 years
  • •BMI > 35 kg/m2
  • •Treated with oral antidiabetic agents and/or insulin
  • •laparoscopic surgery

排除标准

  • •Pharmacological treatment (other then above) witch could affect glucose metabolism
  • •open surgery

研究组 & 干预措施

Modifast

Active Comparator

treated with VLD Modifast 1000 kcal/day in 2 weeks before gastric by-pass,

干预措施: Modifast (Dietary Supplement)

Normal diet

Placebo Comparator

normal diet 2 weeks before gastric by-pass surgery

干预措施: Normal diet (Dietary Supplement)

结局指标

主要结局

Insulin sensitivity

时间窗: 12-18 month after gastric bypass

Insulin sensitivity measured by hyperinsulinemic normoglycemic clamp technique

次要结局

  • Weight reduction(12-18 month after gastric bypass)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anders Thorell

Assoc. Professor

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验